相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Chronic Metformin Associated Cardioprotection Against Infarction: Not Just a Glucose Lowering Phenomenon
Hannah J. Whittington et al.
CARDIOVASCULAR DRUGS AND THERAPY (2013)
Chronic Pretreatment of Metformin is Associated with the Reduction of the No-Reflow Phenomenon in Patients with Diabetes Mellitus After Primary Angioplasty for Acute Myocardial Infarction
Jing-Lin Zhao et al.
CARDIOVASCULAR THERAPEUTICS (2013)
Population Trends in Percutaneous Coronary Intervention 20-Year Results From the SCAAR (Swedish Coronary Angiography and Angioplasty Registry)
Marieke L. Fokkema et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Metformin in non-Diabetic Patients Presenting with ST Elevation Myocardial Infarction: Rationale and Design of the Glycometabolic Intervention as Adjunct to Primary Percutaneous Intervention in ST Elevation Myocardial Infarction (GIPS)-III Trial
Chris P. H. Lexis et al.
CARDIOVASCULAR DRUGS AND THERAPY (2012)
Exenatide Reduces Final Infarct Size in Patients With ST-Segment-Elevation Myocardial Infarction and Short-Duration of Ischemia
Jacob Lonborg et al.
CIRCULATION-CARDIOVASCULAR INTERVENTIONS (2012)
Metformin Prevents the Development of Chronic Heart Failure in the SHHF Rat Model
Antonio Cittadini et al.
DIABETES (2012)
ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
Ph. Gabriel Steg et al.
EUROPEAN HEART JOURNAL (2012)
Effects of metformin on insulin resistance in heart failure. Which came first: the chicken or the egg?
Chris P. H. Lexis et al.
EUROPEAN JOURNAL OF HEART FAILURE (2012)
Metformin overdose causes platelet mitochondrial dysfunction in humans
Alessandro Protti et al.
CRITICAL CARE (2012)
Metformin improves cardiac function in a nondiabetic rat model of post-MI heart failure
Meimei Yin et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2011)
Prognostic Value of Admission Glycosylated Hemoglobin and Glucose in Nondiabetic Patients With ST-Segment-Elevation Myocardial Infarction Treated With Percutaneous Coronary Intervention
Jorik R. Timmer et al.
CIRCULATION (2011)
The cardioprotective effects of metformin
Saloua El Messaoudi et al.
CURRENT OPINION IN LIPIDOLOGY (2011)
Prognostic implications of glucose-lowering treatment in patients with acute myocardial infarction and diabetes: experiences from an extended follow-up of the Diabetes Mellitus Insulin-Glucose Infusion in Acute Myocardial Infarction (DIGAMI) 2 Study
L. G. Mellbin et al.
DIABETOLOGIA (2011)
Metformin: Taking away the candy for cancer?
Mathilde Jalving et al.
EUROPEAN JOURNAL OF CANCER (2010)
Relationship of dysglycemia to acute myocardial infarct size and cardiovascular outcome as determined by cardiovascular magnetic resonance
Adam N. Mather et al.
JOURNAL OF CARDIOVASCULAR MAGNETIC RESONANCE (2010)
Activation of AMP-Activated Protein Kinase by Metformin Improves Left Ventricular Function and Survival in Heart Failure
Susheel Gundewar et al.
CIRCULATION RESEARCH (2009)
Investigation of the effect of oral metformin on dipeptidylpeptidase-4 (DPP-4) activity in Type 2 diabetes
J. Cuthbertson et al.
DIABETIC MEDICINE (2009)
Metformin Prevents Myocardial Reperfusion Injury by Activating the Adenosine Receptor
Marta Paiva et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2009)
Exenatide Reduces Infarct Size and Improves Cardiac Function in a Porcine Model of Ischemia and Reperfusion Injury
Leo Timmers et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Metformin induces cardioprotection against ischaemia/reperfusion injury in the rat heart 24 hours after administration
Lasse Solskov et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2008)
The importance of left ventricular function for long-term outcome after primary percutaneous coronary intervention
Pieter A. van der Vleuten et al.
BMC CARDIOVASCULAR DISORDERS (2008)
Metformin: Effects on micro and macrovascular complications in type 2 diabetes
Clifford J. Bailey
CARDIOVASCULAR DRUGS AND THERAPY (2008)
The effect of metformin treatment on VEGF and PAI-1 Levels in obese type 2 diabetic patients
Canan Ersoy et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2008)
Metformin protects the ischemic heart by the Akt-mediated inhibition of mitochondrial permeability transition pore opening
Gurpreet S. Bhamra et al.
BASIC RESEARCH IN CARDIOLOGY (2008)
Acute metformin therapy confers cardioprotection against myocardial infarction via AMPK-eNOS-mediated signaling
John W. Calvert et al.
DIABETES (2008)
Prognostic value of admission glucose in nondiabetic patients with myocardial infarction
JR Timmer et al.
AMERICAN HEART JOURNAL (2004)
Gadolinium delayed enhancement cardiovascular magnetic resonance correlates with clinical measures of myocardial infarction
WP Ingkanisorn et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2004)
Plasminogen activator inhibitor-1: Physiologic role, regulation, and the influence of common pharmacologic agents
JP Tsikouris et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2002)
The relationships of left ventricular ejection fraction, end-systolic volume index and infarct size to six-month mortality after hospital discharge following myocardial infarction treated by thrombolysis
RJ Burns et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2002)
Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain
MR Owen et al.
BIOCHEMICAL JOURNAL (2000)
分享论文
